Archives of Physiology and Biochemistry, published by Taylor & Francis Ltd, is a renowned journal that has been pivotal in advancing knowledge and research in the fields of physiology and biochemistry since its inception. With an impact factor reflective of its significant contributions, this journal is categorized in Q2 in Medicine (miscellaneous) and Q3 in Physiology, underscoring its relevance and scholarly impact within the scientific community. The journal publishes original research articles, review papers, and innovative methodologies that explore the intricate relationships between physiological functions and biochemical processes. With its commitment to fostering scientific discourse, the Archives of Physiology and Biochemistry serves as an essential resource for researchers, professionals, and students alike, providing insights and evidence that drive forward the frontiers of medical and physiological science. The journal is accessible in both print and online formats, ensuring that critical research reaches a wide audience.

Photodiagnosis and Photodynamic Therapy is a leading journal published by Elsevier, specializing in the fields of biophysics, dermatology, oncology, and pharmacology. With an impressive Q2 ranking across multiple categories in the 2023 category quartiles, this journal is pivotal for researchers and practitioners aiming to advance their knowledge and expertise in photodiagnostic and therapeutic techniques. Since its inception in 2004, it has provided a critical platform for peer-reviewed articles exploring the latest advancements and applications in light-based treatments. As of 2024, the journal will be fully Open Access, enhancing its accessibility and reach across the scientific community. Located in Amsterdam, Netherlands, this journal's commitment to fostering innovation and collaboration makes it an essential resource for those interested in the intersection of light-based technologies and medicine. With its high visibility in key indexed databases like Scopus, researchers can trust that their contributions will be well-regarded and widely disseminated.

The JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, published by the American Society for Pharmacology and Experimental Therapeutics, stands as a pivotal platform in the fields of pharmacology and molecular medicine. With an impressive convergence of knowledge from 1945 to 2024, this esteemed journal is recognized for its rigorous peer-reviewed research, contributing significantly to our understanding of drug action and therapeutic interventions. It holds a commendable position in the Q2 quartile in both Molecular Medicine and Pharmacology, emphasizing its relevance and impact within the contemporary scientific landscape, as evidenced by its Scopus ranking that places it amongst the leading journals in its category. Aimed at researchers, professionals, and students, the journal not only fosters a deeper insight into toxicology, pharmacodynamics, and therapeutic strategies but also encourages innovation through its comprehensive access to groundbreaking experimental methodologies. The journal continues to foster discourse and disseminate research that shapes the future of pharmacological science.

Diving and Hyperbaric Medicine is a premier journal published by the SOUTH PACIFIC UNDERWATER MEDICAL SOCIETY that focuses on the critical intersection of diving medicine and hyperbaric physiology. With an ISSN of 1833-3516, this journal has become an essential resource for researchers, healthcare professionals, and students interested in the fields of public health, environmental health, and occupational health, as reflected in its Q3 ranking in the 2023 category quartiles. Since its inception in 2006, it has consistently provided high-quality peer-reviewed articles that address the latest clinical practices, research findings, and technological advancements in underwater medicine. Supporting a broad readership with its commitment to knowledge dissemination, Diving and Hyperbaric Medicine serves as a valuable platform for sharing innovations and challenges faced in hyperbaric treatments and diving safety protocols. Although not currently open access, it remains a recognized journal with significant contributions to the field, housed in Australia, at C/O AUSTRALIAN & NEW ZEALAND COLL ANAESTHETISTS, 630 ST KILDA RD, MELBOURNE VIC 3004, AUSTRALIA. Join the academic discourse and explore insights vital for improving diving safety and health outcomes in this dynamic domain.

The British Journal of Anaesthesia is a leading peer-reviewed journal published by Elsevier Science Ltd, dedicated to advancing the field of anesthesiology and pain medicine. Since its inception in 1923, this prestigious journal has served as a vital resource for clinicians, researchers, and students, providing high-quality research articles, reviews, and clinical guidelines. With an impressive impact factor and a Scopus rank of #2 out of 136 in its category, it stands out as a Q1 journal, reflecting its significance and influence in the medical community. The journal aims to disseminate innovative research findings, enhance clinical practice, and contribute to the education of healthcare professionals globally. Although it does not offer open access, its rich archive and ongoing publication in the dynamic field of anesthesiology make it an essential reference for those seeking to stay at the forefront of this critical discipline. For more information, visit the journal’s dedicated webpage.

Welcome to the KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, a leading publication in the field of medicine dedicated to advancing knowledge and innovation in medical sciences. Published by the esteemed WILEY, this Open Access journal has been a vital resource for researchers, professionals, and students since its establishment. With a commitment to disseminate high-quality research, the journal enjoys a commendable impact factor and ranks in the Q2 category in Medicine (Miscellaneous), highlighting its significance within the academic community. The journal covers a broad spectrum of topics and has been recognized for its contributions, holding a notable position in the Scopus Rankings as #83 out of 636 in General Medicine, placing it in the 87th percentile. Based in Singapore, the KJMS provides an essential platform for knowledge exchange, fostering collaboration and engagement among medical professionals worldwide. Join us in exploring pioneering research that shapes the future of healthcare.

Acupuncture in Medicine, hosted by SAGE PUBLICATIONS LTD, is a prestigious journal dedicated to the growing field of acupuncture and its applications within medicine. With an ISSN of 0964-5284 and an E-ISSN of 1759-9873, this journal serves as an essential resource for clinicians, researchers, and students alike, providing a platform to advance understanding and evidence-based practices in the utilization of acupuncture. Recognized for its impactful contributions, it holds a commendable Q2 ranking in Complementary and Alternative Medicine and a Q3 ranking in both Medicine (miscellaneous) and Neurology (clinical). This journal fosters interdisciplinary dialogue and innovation while adhering to rigorous academic standards, making it a vital reading for anyone interested in the therapeutic potential of acupuncture. With an impressive array of articles published since 1996, Acupuncture in Medicine remains committed to exploring new horizons in integrative medicine, thereby enhancing clinical practice and patient care.

INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, published by Taylor & Francis Ltd, has established itself as a premier forum for the dissemination of innovative research related to radiation biology, covering emerging topics that are crucial within the fields of radiology, nuclear medicine, and ultrasound technology. With an ISSN of 0955-3002 and an E-ISSN of 1362-3095, this journal spans over six decades, from its inception in 1959 to 2024, reflecting a rich history of scholarly contribution and a dynamic approach to addressing current challenges in the discipline. Its reputation is highlighted by its Q2 rankings in both Radiology, Nuclear Medicine and Imaging and Radiological and Ultrasound Technology for 2023, underscoring its relevance in a competitive academic landscape, with Scopus rankings placing it in the top tier of its category. While operating under a traditional access model, the journal aims to connect researchers, professionals, and students, facilitating the advancement of knowledge and fostering a deeper understanding of the impact of radiation in various medical applications. The journal plays an essential role in shaping future research directions and enhancing clinical practices globally.

Neuropeptides is a prestigious, peer-reviewed journal published by Elsevier, focusing on the critical role of neuropeptides in various biological processes and their implications in cellular and molecular neuroscience, endocrinology, and neurology. With an impact factor reflecting its influence in the field and a diverse audience ranging from researchers to healthcare professionals, the journal serves as an essential platform for the dissemination of groundbreaking research from 1980 to 2024. Adhering to high academic standards, Neuropeptides holds a Q3 ranking in Cellular and Molecular Neuroscience and Endocrine and Autonomic Systems, alongside a solid Q2 ranking in both Endocrinology and Neurology. This positions the journal at the forefront of its disciplines, contributing valuable insights into the understanding of neuropeptide functions in health and disease. By not operating as an Open Access journal, it ensures sustainability in the publishing process while upholding rigorous review standards. Researchers, professionals, and students are encouraged to engage with the findings published in this journal, which plays a vital role in advancing knowledge and fostering collaboration within the neuroscientific community.

Phytotherapy Research, a distinguished journal published by Wiley, stands at the forefront of the pharmacological literature, delivering essential insights into the therapeutic potential of plant-based interventions. With its ISSN 0951-418X and E-ISSN 1099-1573, the journal has firmly established itself since its inception in 1987, now converging into its 2024 volume. Notably positioned in the Q1 category of Pharmacology and ranked #22 out of 313 journals in the field, it boasts a remarkable 93rd percentile rating according to Scopus. While the journal adheres to subscription-based access, it remains a crucial repository of high-quality research findings that support the understanding and advancement of herbal medicines and phytotherapeutics. This journal serves as an invaluable resource for researchers, healthcare professionals, and students alike, fostering a deeper exploration of the synergistic relationship between nature and medicine and promoting evidence-based practices in the field.